MUDDY/insights

← Case indexLFT

Longtop Financial Technologies (NYSE: LFT)

Citron's April 2011 short, Deloitte's May 2011 resignation letter, and the SEC's signature fraud case of the 2011 China-short wave.

Key FactDetail
ReportForensic Short — Closed Case
Publication dateDecember 15, 2013
IssuerLongtop Financial Technologies Limited (Cayman / China financial-software issuer)
TickerNYSE: LFT (delisted)
Original shortCitron Research — "Longtop Financial: Citron Reports on the Audit" (April 2011); contemporaneous work by Carson Block / Muddy Waters and others
Headline post-publication eventsDeloitte Touche Tohmatsu CPA Ltd. resigns as auditor with unusually direct public letter (May 22, 2011); NYSE trading suspension and delisting; SEC fraud charges against Longtop and former CFO; SEC enforcement against audit personnel
RatingSHORT — Closed Case

Why We Are Publishing Today

Longtop Financial Technologies is the signature case of the 2011 China-listed-issuer forensic-short wave. The May 22, 2011 resignation letter from Longtop's auditor, Deloitte Touche Tohmatsu CPA Ltd., is among the most-cited single documents in modern forensic accounting: Deloitte alleged that bank confirmations the firm had previously received were not genuine and that company officers had interfered with the audit process. The subsequent NYSE delisting and SEC enforcement constitute one of the cleanest closed-loop confirmations in the genre.


Section 1 — The Citron Thesis (April 2011)

Citron Research's April 2011 commentary on Longtop Financial — alongside parallel short-side work by Carson Block / Muddy Waters, Jon Carnes / Alfred Little, and others — alleged that Longtop:

  • Misrepresented its underlying banking-software customer relationships;
  • Inflated reported revenue and earnings;
  • Carried disclosed cash balances at China banking institutions that materially exceeded the cash the operating business could plausibly generate.

Citron disclosed a short position.

Section 2 — The Deloitte Resignation Letter (May 22, 2011)

The post-publication sequence was unusually rapid, and unusually well-documented at the auditor level. On May 22, 2011, Deloitte Touche Tohmatsu CPA Ltd. resigned as Longtop's auditor and filed a public resignation letter with content that has been re-circulated in subsequent forensic-accounting literature:

  • The letter alleged that, in attempting to verify cash balances at certain Chinese banks during the 2010 annual audit, Deloitte had received bank confirmations that the firm subsequently determined had been fabricated;
  • The letter alleged that Longtop officers had interfered with the audit process, including by directing bank staff to provide false confirmations;
  • The letter stated that Deloitte was unable to rely on previously-issued financial statements that the firm had audited.

The directness of the public resignation letter is unusual for a Big-Four auditor and remains the most-cited single example in the modern China-short canon.

Section 3 — NYSE Delisting and SEC Enforcement

  • May 2011 onward. NYSE trading suspension; delisting follows.
  • November 2011. SEC files civil fraud charges against Longtop Financial Technologies and former CFO Derek Palaschuk.
  • Subsequent dispositions. Default judgment against Longtop; contested civil-procedure outcomes against Palaschuk. Permanent bars and civil money penalties against named individuals.
  • Parallel SEC action against Deloitte's Chinese audit affiliate under Section 106 of the Sarbanes-Oxley Act, in connection with requests for audit working papers — a track that became part of the broader HFCAA / China audit-access controversy that recurred through the 2010s and ultimately resulted in the 2022 PCAOB inspection access agreement.

Common equity in Longtop Financial was effectively zero in subsequent dispositions.

Section 4 — Where Things Stand (December 2013) and What Muddy Insights Takes From The Case

As of December 2013:

  • Longtop Financial Technologies is defunct as a US-listed entity;
  • SEC enforcement matters are substantively closed;
  • The case is foundational in the post-2011 PCAOB / HFCAA literature on China-audit access.

What Muddy Insights takes from the Longtop case:

  1. Fabricated bank confirmations are the cleanest forensic signal. The Deloitte May 2011 resignation letter remains the gold-standard auditor-disavowal document in the modern China-short literature.
  2. The case catalyzed the China-audit-access policy track. The subsequent PCAOB / HFCAA / SEC Section 106 contestation, which ran for more than a decade and resolved partially in the 2022 PCAOB-CSRC inspection-access agreement, was substantively triggered by the Longtop and adjacent 2011-cohort cases.
  3. 2011 was a watershed cohort. The Longtop case sits alongside Sino-Forest, China MediaExpress, and others in a single calendar year that re-set the disclosure baseline for US-listed Chinese issuers.

Source Index (selected)

  • Citron Research, "Longtop Financial: Citron Reports on the Audit," April 2011.
  • Deloitte Touche Tohmatsu CPA Ltd. — auditor resignation letter / public disclosure, May 22, 2011.
  • US Securities and Exchange Commission — SEC v. Longtop Financial Technologies Limited and Derek Palaschuk, civil-fraud filing, November 2011.
  • SEC Section 106 (Sarbanes-Oxley Act) proceedings against Deloitte Touche Tohmatsu CPA Ltd. relating to Longtop audit working papers.
  • PCAOB and SEC public statements on the post-2011 China-audit-access track, through to the 2022 PCAOB-CSRC inspection-access agreement.

— Muddy Insights, December 15, 2013.

// More files

  1. 028CURR · 2026-10-21Currenc Group Inc. (NASDAQ: CURR) — Forensic FileA Charging Order Over The Only Asset That Matters. The Same 100,465 Tranglo Shares Sold For US$400M Are Now Charged To A Judgment Creditor.NOT RATED — Forensic File
  2. 027DLXY · 2026-07-21Delixy Holdings Ltd. (NASDAQ: DLXY) — Forensic Short ReportThe IPO Funded An Exit, Not An Expansion. Dividends Out 4x What The Public Put In.NOT RATED — Research case study
  3. 026TROO · 2026-07-15TROOPS, Inc. (NASDAQ: TROO) — Forensic Short UpdateThe August 20 Endgame: Winding-Up Exposure, Suspension Mechanics, And A Support Bid Running On FumesSHORT — High conviction
  4. 025ADANIENT · 2026-05-15Adani Enterprises (NSE: ADANIENT)Three years after Hindenburg, two years after OCCRP, eighteen months after the EDNY indictment — what the public record now shows.SHORT — Update
  5. 024TROO · 2026-05-05TROOPS, Inc. (NASDAQ: TROO) — Forensic Short UpdateAuditor Replaced. Lock-Up Eased. Annual Report Past Due.SHORT — High conviction
  6. 023TRE · 2026-04-15Sino-Forest Corporation (TSX: TRE)The founding case of the modern China-short genre — fifteen years on.SHORT — Closed Case
  7. 022BUR · 2026-03-30Burford Capital (NYSE/LSE: BUR)Six years on from Muddy Waters' mismarking thesis — what the Second Circuit's March 2026 reversal of the YPF judgment changes.NEUTRAL
  8. 021IEP · 2026-02-25Icahn Enterprises L.P. (NASDAQ: IEP)Three years after Hindenburg's "Pied Piper of Pumpland" — distributions, the SEC settlement, and the margin-loan unwind.SHORT — Update
  9. 020WDI · 2026-02-01Wirecard AG (XETRA: WDI) — Closed-Case RetrospectiveSix years after the €1.9B missing cash — what a streamlined trial, a €140M civil award, and the Marsalek-as-FSB-asset disclosures now confirm.SHORT — Closed Case
  10. 019NKLA · 2026-01-15Nikola Corporation (NASDAQ: NKLA)The Hindenburg short, the Milton conviction, the Trump pardon, and the company's own Chapter 11.SHORT — Closed Case
  11. 018MAGH · 2025-12-02Magnitude International Ltd. (NASDAQ: MAGH) — Forensic ShortPenny-Priced Pre-IPO Equity, Eight-Month Cashout, Resale Shelf Engineered for Insider Exit.SHORT — High conviction
  12. 017VRX · 2025-10-21Valeant Pharmaceuticals (NYSE: VRX, now Bausch Health: BHC)Citron's "Pharmaceutical Enron" call, the Philidor disclosure, and the ten-year recovery that never came.SHORT — Closed Case
  13. 016TIO · 2025-09-01Tingo Group (NASDAQ: TIO)Hindenburg's June 2023 short, SEC fraud charges, the $250M civil judgment, and the founder still at large.SHORT — Closed Case
  14. 015EBIX · 2024-09-15Ebix, Inc. (NASDAQ: EBIX)Hindenburg's June 2021 short, the December 2023 Chapter 11, the $400M Zinnia sale, and the August 2024 emergence under Eraaya LifeSpaces sponsorship.SHORT — Update
  15. 014FFGRP · 2024-07-15Folli Follie (ATHEX: FFGRP)QCM's May 2018 short, the largest stock-market fraud in modern Greek history, and the June 2024 prison sentences.SHORT — Closed Case
  16. 013SNH · 2024-04-15Steinhoff International (JSE: SNH)Viceroy's December 2017 short, €7B+ of confirmed accounting irregularities, and the July 2023 vote to dissolve.SHORT — Closed Case
  17. 012RIDE · 2024-04-01Lordstown Motors (NASDAQ: RIDE, now Nu Ride: NRDE)From SPAC pre-orders to Chapter 11 to a litigation-vehicle reorganization.SHORT — Closed Case
  18. 011GSX · 2022-09-15GSX Techedu (NYSE: GSX, now Gaotu: GOTU)Muddy Waters' May 2020 short, the July 2021 "double reduction" policy that vindicated the broader sector thesis, and the 2022 HFCAA delisting.SHORT — Closed Case
  19. 010EROS · 2022-05-15Eros International / Eros STX Global (NYSE: EROS, formerly)Kerrisdale's November 2015 short, the 2020 merger with STX Entertainment, and the 2022 separation that effectively ended the listed parent.SHORT — Closed Case
  20. 009QPP · 2021-09-15Quindell PLC (LSE AIM: QPP, now Watchstone)Gotham City Research's April 2014 short, the £637M Slater & Gordon sale, the £11M settlement that followed, and the SFO investigation that ended without charge.SHORT — Closed Case
  21. 008SONG · 2020-10-15Akazoo S.A. (NASDAQ: SONG)QCM's April 2020 short, SEC fraud charges, and the fastest US-regulator resolution of a SPAC-era fraud.SHORT — Closed Case
  22. 007INSY · 2020-02-15Insys Therapeutics (NASDAQ: INSY)Citron's August 2016 short, the Subsys opioid-marketing prosecution, the June 2019 bankruptcy, and the first US pharmaceutical-executive RICO conviction for opioid marketing.SHORT — Closed Case
  23. 006ON · 2020-01-15Bio-on S.p.A. (Borsa Italiana AIM: ON) — Forensic Short Closed CaseAuditor-quality bioplastics revenue, a same-quarter founder arrest, and the fastest closure of any modern European forensic-short case.SHORT — Closed Case
  24. 005N21 · 2019-01-15Noble Group (SGX: N21)Iceberg Research's February 2015 short, multi-year mark-to-model contestation, and the 2018 break-up of one of Asia's largest commodity traders.SHORT — Closed Case
  25. 004NQ · 2018-01-15NQ Mobile (NYSE: NQ)Muddy Waters' October 2013 short, four years of contested public posture, and the eventual NYSE delisting in 2017.SHORT — Closed Case
  26. 003FMCN · 2015-09-15Focus Media (NASDAQ: FMCN, formerly)Muddy Waters' November 2011 short, the 2013 take-private at a premium, and the 2015 China A-share relisting at a multiple of the take-private price.SHORT — Counter-Case
  27. 002GOW · 2014-08-01Let's Gowex (BME MAB: GOW)Gotham City Research's July 2014 short, the CEO confession within days, and the fastest forensic-short to bankruptcy in the modern catalogue.SHORT — Closed Case
  28. 001CCME · 2013-12-15China MediaExpress Holdings (NASDAQ: CCME)Muddy Waters' February 2011 short, auditor Deloitte's resignation, and the SEC fraud charges that followed.SHORT — Closed Case